Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Penny Pricing” Guidance Document On Hold Until 340B Office Gets Funding

Executive Summary

A long-promised official policy on "penny pricing" for drugs sold to 340B entities is on hold until Congress appropriates funding for the Health Resources and Services Administration's Office of Pharmacy Affairs. Until then, drug manufacturers will need to work on a case-by-case basis with OPA to resolve any pricing issues

You may also be interested in...



Problems With 340B? GAO Is Now Gathering Information From Drug Manufacturers

The Government Accountability Office has begun interviewing pharmaceutical manufacturers about their experiences with the 340B drug discount program in preparation for a report mandated by the Affordable Care Act.

340B Drug Allocation Provision In Tax Bill Needs Clarification, Attorney Says

A provision in a tax bill passed by the House May 28 would require manufacturers facing a shortage of an inpatient drug used by 340B program hospitals to submit a drug allocation plan to HHS for approval

340B Drug Allocation Provision In Tax Bill Needs Clarification, Attorney Says

A provision in a tax bill passed by the House May 28 would require manufacturers facing a shortage of an inpatient drug used by 340B program hospitals to submit a drug allocation plan to HHS for approval

Related Content

UsernamePublicRestriction

Register

PS050025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel